- Home
- PLAY vs CDNA Comparison
PLAY vs CDNA Comparison
Compare PLAY & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLAY
- CDNA
- Stock Information
- Founded
- PLAY 1982
- CDNA 1998
- Country
- PLAY United States
- CDNA United States
- Employees
- PLAY N/A
- CDNA N/A
- Industry
- PLAY Restaurants
- CDNA Medical Specialities
- Sector
- PLAY Consumer Discretionary
- CDNA Health Care
- Exchange
- PLAY Nasdaq
- CDNA Nasdaq
- Market Cap
- PLAY 971.8M
- CDNA 1.1B
- IPO Year
- PLAY 1995
- CDNA 2014
- Fundamental
- Price
- PLAY $24.07
- CDNA $21.44
- Analyst Decision
- PLAY Buy
- CDNA Buy
- Analyst Count
- PLAY 9
- CDNA 8
- Target Price
- PLAY $56.00
- CDNA $26.43
- AVG Volume (30 Days)
- PLAY 1.9M
- CDNA 851.0K
- Earning Date
- PLAY 12-10-2024
- CDNA 02-26-2025
- Dividend Yield
- PLAY N/A
- CDNA N/A
- EPS Growth
- PLAY N/A
- CDNA N/A
- EPS
- PLAY 2.10
- CDNA N/A
- Revenue
- PLAY $2,197,200,000.00
- CDNA $312,775,000.00
- Revenue This Year
- PLAY $0.26
- CDNA $19.85
- Revenue Next Year
- PLAY $5.38
- CDNA $11.34
- P/E Ratio
- PLAY $11.47
- CDNA N/A
- Revenue Growth
- PLAY 1.25
- CDNA 5.26
- 52 Week Low
- PLAY $22.83
- CDNA $7.42
- 52 Week High
- PLAY $69.82
- CDNA $34.84
- Technical
- Relative Strength Index (RSI)
- PLAY 29.64
- CDNA 43.79
- Support Level
- PLAY $22.83
- CDNA $21.09
- Resistance Level
- PLAY $32.40
- CDNA $25.95
- Average True Range (ATR)
- PLAY 1.51
- CDNA 1.61
- MACD
- PLAY -0.29
- CDNA 0.02
- Stochastic Oscillator
- PLAY 12.96
- CDNA 19.46
About PLAY Dave & Buster's Entertainment Inc.
Dave & Buster's Entertainment Inc owns and operates nearly a hundred entertainment and dining establishments in the United States where customers can eat, drink, play games, and watch televised sports. Each store offers a full menu of entries and appetizers, a complete selection of alcoholic and non-alcoholic beverages, and an extensive assortment of entertainment attractions centered around playing games and watching live sports and other televised events. It derives maximum revenue from Entertainment.
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.